Diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: From January 1, 2022 to August 1, 2023, 72 healthy normals and 72 diabetic patients who visited the endocrinology department of Dalian Central Hospital were included in the study and were divided into healthy normals and diabetic groups.The criteria were as follows: subjects were 18-70 years of age, of either sex; healthy subjects able to eat normally and be active or diagnosed with diabetes; understood the entire study process, voluntarily participated and signed an informed consent form.
Exclusion criteria
Exclusion criteria: Exclude those who cannot tolerate the sensor as assessed by qualified personnel; subjects with any unresolved adverse skin disease (e.g., psoriasis, rash, staph infection) in the area of the sensor or device placement; subjects who are fertile females with a positive pregnancy screening test; subjects who have had a hypoglycemic seizure or hypoglycemia resulting in loss of consciousness or a history of Diabetic ketoacidosis (DKA) within 6 months prior to enrollment; subject has a history of seizures; subject has a central nervous system disorder or heart disease that causes syncope; subject has a cardiac disorder; subject has a history of adrenal insufficiency.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sweat Glucose;Fingertip blood glucose;Intravenous blood glucose;Ambulatory blood glucose monitoring;Glycated hemoglobin;Fasting blood sugar; | — |
Secondary
| Measure | Time frame |
|---|---|
| Waist Circumference;Abdominal circumference;Body composition analysis; | — |
Countries
China
Contacts
Dalian Central Hospital